Five foods that release the same ‘fullness' hormone as Ozempic
The medicines regulator has since approved a higher dose under the brand name Wegovy to treat obesity. The active ingredient in both drugs is semaglutide, which works by mimicking the action of the GLP-1 hormone, a compound generally released by the gut after a meal. GLP-1 signals to the brain that we are full, preventing us from overeating.
Understandably, you may be hesitant to inject yourself with a drug, and the side-effects aren't pleasant either, from nausea to constipation and heartburn. Thankfully, we can all regulate our appetite more naturally by eating foods that trigger the release of the same fullness hormone as Ozempic. One of our favourite snacks could help stave off hunger pangs; scientists have invented a dark chocolate biscuit – with an extra ingredient that works like Ozempic - which has similar hunger-suppressing effects.
Following are the top five best foods to keep you feeling full.
Oats and whole grains
Always first to jump on a trend, those zealous TikTokers have been all over this one with the recent 'Oatzempic' raze – an oat-rich smoothie touted as 'Ozempic in a glass'. They may be on to something. If you are partial to a morning bowl of porridge, you'll already know how filling it is. A 2016 study found that the soluble fibre contained in oats and other whole grains is fermented by the gut, producing short-chain fatty acids (SCFAs) which stimulate GLP-1 release.
If you're not a fan of porridge's gloopy texture, why not blend some oats into a smoothie along with other fibre-rich ingredients for a satiating start to the day? Place 2 tbsp oats in a blender, pulse a few times to grind before adding 100g frozen mixed berries, a small ripe banana, 1 tbsp peanut butter and 100ml milk. Blend until smooth and drink straight away.
Eggs
Not only are eggs rich in protein, which takes longer to digest than fat or carbohydrate and so keeps us feeling full for longer, but recent research has found that egg whites contain peptides that stimulate GLP-1 production. But don't worry, there's no need to resort to tasteless egg-white omelettes. The yolks contain an abundance of essential nutrients including vitamins B2, B12 and D, choline, selenium and iodine, and research shows that the cholesterol in eggs does not significantly raise levels of 'bad' cholesterol in our blood.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Perth Now
10 hours ago
- Perth Now
Serena Williams sheds 30lbs with weight-loss medication
Serena Williams has lost over 30lbs with the aid of weight-loss medication. The tennis champion found it hugely "frustrating" when she was unable to get her pre-pregnancy physique back after giving birth to daughter Olympia in 2017 and faced similar struggles when her second daughter Adira was born in August 2023. She told People magazine: '[After Olympia]I never was able to get to the weight I needed to be no matter what I did, no matter how much I trained. 'It was crazy because I'd never been in a place like that in my life where I worked so hard, ate so healthy and could never get down to where I needed to be at. 'I had never taken shortcuts in my career and always worked really hard. I know what it takes to be the best. So it was very frustrating to do all the same things and never be able to change that number on the scale or the way my body looked.' Serena told how she lost a lot of weight in the two weeks after she and husband Alexis Ohanian welcomed their second daughter into the world, but then nothing else. She recalled: 'I just thought, gosh, I don't know if I would ever be able to get back to where I needed to get to." Serena then turned to healthcare company Ro, who guided her in choosing a GLP-1 treatment - which includes the likes of Ozempic and Mounjaro - but was hesitant before going ahead. She said: 'I did a lot of research on it. I was like, 'is this a shortcut? What are the benefits? What are not the benefits?' I really wanted to dive into it before I just did it."" After stopping breastfeeding when Adira was six months old, Serena was able to start the weekly injections and now she feels better than ever. She said: 'They were super supportive and it was easy to get the medication. I lost over 31 pounds using my GLP-1 and I was really excited about that weight loss. 'I just can do more. I'm more active. My joints don't hurt as much. I just feel like something as simple as just getting down is a lot easier for me. And I do it a lot faster. I feel like I have a lot of energy and it's great. I just feel pretty good about it." The 23-time Grand Slam champion stressed that she's continued to exercise and eat healthily alongside the medication. She said: 'GLP-1 helped me enhance everything that I was already doing — eating healthy and working out, whether it was as a professional athlete at the top level of tennis or just going to the gym every day. 'So I think that it's important for everyone to hear my story. And I feel like there's a lot of people that can relate.'
Perth Now
2 days ago
- Perth Now
Cats and dogs could get fat jabs
Weight-loss jabs could soon be administered to cats and dogs. Veterinary equivalents of drugs such as Wegovy and Mounjaro are being developed and tested by boffins and could be delivered to canines and felines via implants. Early clinical trials in cats have revealed that small doses of the drug exenatide - which works similarly to the anti-obesity medication semaglutide - are effective when it comes to reducing the calorie intake and body weight of animals. A trial last year fitted five moggies with an experimental implant known as OKV-119, which released the chemical into the animal's blood for 84 days. Analysis revealed that four of five cats had a reduction in body mass of at least five per cent. The trial is now being extended to dogs in a partnership with drug companies Okava and Vivani and the medication could be available as early as 2028 should it be successful. Michael Klotsman, the chief executive of Okava, told The Guardian newspaper: "What owners should expect to see is their pet eating appropriate portions without the previous food obsession - they'll still eat regularly and show interest in meals, just without the excess begging, scavenging or gulping behaviour."
The Age
3 days ago
- The Age
Ozempic maker cuts price of wonder drug in half in US
Novo Nordisk is slashing the cost of Ozempic for cash-paying patients after the diabetes shot became the poster child for high US drug prices. Patients can now get Ozempic for $US499 ($768) a month — about half of its US list price — through Novo's cash-pay pharmacy NovoCare, the company said in a statement on Monday. It's also partnering with GoodRx Holdings to offer Ozempic and its sister weight-loss drug Wegovy for the same price at pharmacies across the US. President Donald Trump has been putting pressure on pharmaceutical companies to lower prices, including sending letters to drugmakers like Novo demanding action. The Biden administration previously attempted to get Novo to lower the price of Ozempic, the Danish company's best-selling drug, without success. Novo said the offer is unrelated to its discussions with the US government. It comes less than a week after weight-loss rival Eli Lilly & Co. made its own adjustment, raising the list price for its obesity shot in the UK by as much as 170 per cent. Still, it's not yet clear how much difference either measure will make when it comes to variations in what patients actually pay across countries. Novo's shares gained as much as 7.8 per cent to a session high following the announcement. The stock was already advancing on Monday after Wegovy received Food and Drug Administration approval to treat a serious form of liver disease. The news also sent GoodRx's stock up 39 per cent, its biggest intraday jump since September 2020. GoodRx Chief Executive Officer Wendy Barnes said the partnership with Novo makes it much easier for patients to get a more affordable version of the drugs. 'We are the number one branded marketplace to seek cash pricing on brands and generics, so for that reason we already have the millions of consumers searching for these types of products,' Barnes said in an interview with Bloomberg TV. 'This is where they are looking for the most affordable price and the ability to access them.' Novo first started selling Wegovy directly to consumers in March, following Lilly's earlier example. Both drugmakers have been contending with the widespread use of less expensive, copycat versions of their shots — known as compounded drugs — that became popular during supply shortages.
